- Home
- OIA vs SOPH Comparison
OIA vs SOPH Comparison
Compare OIA & SOPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | OIA | SOPH |
|---|---|---|
| Founded | N/A | 2011 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Finance Companies | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.4M | 462.3M |
| IPO Year | 1994 | 2021 |
Fundamental Metrics
Financial Performance| Metric | OIA | SOPH |
|---|---|---|
| Price | $5.47 | $8.35 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.50 |
| AVG Volume (30 Days) | 132.0K | ★ 624.7K |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $23.09 |
| Revenue Next Year | N/A | $19.57 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $5.42 | $3.75 |
| 52 Week High | $6.40 | $8.98 |
Technical Indicators
Market Signals| Indicator | OIA | SOPH |
|---|---|---|
| Relative Strength Index (RSI) | 24.26 | 57.08 |
| Support Level | N/A | $4.63 |
| Resistance Level | $6.22 | $8.84 |
| Average True Range (ATR) | 0.10 | 0.40 |
| MACD | -0.04 | -0.04 |
| Stochastic Oscillator | 4.84 | 68.38 |
Price Performance
Historical ComparisonAbout OIA Invesco Municipal Income Opportunities Trust
Invesco Municipal Income Opportunities Trust is a closed-end management investment company. The Trust's investment objective is to provide a high level of current income which is exempt from federal income tax.
About SOPH SOPHiA GENETICS SA
Sophia Genetics SA is a healthcare technology company dedicated to establishing the practice of data-driven medicine as the standard of care and for life sciences research. It has built a cloud-based SaaS platform capable of analyzing data and generating insights from complex multimodal data sets and different diagnostic modalities. The Company had a physical presence in three countries outside of its headquarters in Switzerland: France, the United States, and Brazil.